DOW
44
10
BA
54
5
PFG
45
3
NDAQ
62
2
RHI
59
2
VTR
47
-7
URBN
56
14
PEP
48
6
BWA
48
2
EXC
53
-3
MRK
25
-2
VRSN
53
-4
NAVI
52
5
UA
50
-9
AXP
71
2
PAYX
53
2
FSLR
54
7
LH
43
-2
APD
59
2
ILMN
42
5
DOW
44
10
BA
54
5
PFG
45
3
NDAQ
62
2
RHI
59
2
VTR
47
-7
URBN
56
14
PEP
48
6
BWA
48
2
EXC
53
-3
MRK
25
-2
VRSN
53
-4
NAVI
52
5
UA
50
-9
AXP
71
2
PAYX
53
2
FSLR
54
7
LH
43
-2
APD
59
2
ILMN
42
5
Financhill
Back

Akebia Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
63

AKBA
Akebia Therapeutics

Last Price:
1.87
Seasonality Move:
46.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Akebia Therapeutics Price Quote

$1.87
-0.01 (2.75%)
(Updated: November 23, 2024 at 5:24 AM ET)

Akebia Therapeutics Key Stats

Buy
63
Akebia Therapeutics (AKBA) is a Buy
Day range:
$1.81 - $1.90
52-week range:
$0.80 - $2.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.25
P/B ratio:
0%
Volume:
2M
Avg. volume:
2.2M
1-year change:
89.9%
Market cap:
$410.2M
Revenue:
$194.6M
EPS:
$-0.23

How Much Does Akebia Therapeutics Make?

Is Akebia Therapeutics Growing As A Company?

  • What Is Akebia Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.11%
  • What Is Akebia Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Akebia Therapeutics Stock Price Performance

What Is Akebia Therapeutics 52-Week High & Low?

Akebia Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Akebia Therapeutics?

Is Akebia Therapeutics Cash Flow Positive?

  • What Is AKBA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$38.5M
  • What Is Akebia Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $26M
  • What Is Akebia Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$31K

Akebia Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    AKBA return on invested capital is -9553.8%
  • What Is Akebia Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -20.36%
  • What Is AKBA Return On Equity?
    ROE is a measure of profitability and is 0%

Akebia Therapeutics Earnings Date & Stock Price

Akebia Therapeutics Competitors

Akebia Therapeutics Dividend Yield

Akebia Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -100%
Revenue: -10.98% -15.9%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 5.50
Upside from Last Price: 192.55%

Major Shareholders

  • How many AKBA shares are owned by institutional investors?
    94.7M AKBA shares are owned by institutional investors
  • How many AKBA shares are owned by insiders?
    7.9M AKBA shares are owned by insiders